stoxline Quote Chart Rank Option Currency Glossary
  
Mesa Laboratories, Inc. (MLAB)
100.74  1.12 (1.12%)    04-19 16:00
Open: 98.91
High: 101.825
Volume: 25,997
  
Pre. Close: 99.62
Low: 98.91
Market Cap: 543(M)
Technical analysis
2024-04-19 5:10:57 PM
Short term     
Mid term     
Targets 6-month :  124.85 1-year :  131.45
Resists First :  106.89 Second :  112.55
Pivot price 103.16
Supports First :  97.75 Second :  81.32
MAs MA(5) :  101.69 MA(20) :  103.48
MA(100) :  101.02 MA(250) :  115.75
MACD MACD :  -0.8 Signal :  -0.3
%K %D K(14,3) :  18.5 D(3) :  24.8
RSI RSI(14): 44.9
52-week High :  178.63 Low :  82.86
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ MLAB ] has closed above bottom band by 32.0%. Bollinger Bands are 16.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 102.06 - 102.74 102.74 - 103.35
Low: 97.24 - 98.1 98.1 - 98.88
Close: 99.41 - 100.77 100.77 - 101.99
Company Description

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Headline News

Sat, 20 Apr 2024
Mesa Labs (MLAB) Stock Sinks As Market Gains: What You Should Know - Yahoo Movies Canada

Fri, 19 Apr 2024
Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates - Yahoo Canada Shine On

Fri, 19 Apr 2024
Mesa Laboratories (NASDAQ:MLAB) Share Price Passes Above 200 Day Moving Average of $99.57 - MarketBeat

Thu, 18 Apr 2024
The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable - Yahoo Finance UK

Wed, 17 Apr 2024
Investors in Mesa Laboratories (NASDAQ:MLAB) have made a strong return of 153% over the past five years - Yahoo Movies UK

Sat, 06 Apr 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) Plans $0.16 Quarterly Dividend - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Technology
Industry:
Hardware, Equipment & Parts
Shares Out 5 (M)
Shares Float 5 (M)
Held by Insiders 5.7 (%)
Held by Institutions 91.8 (%)
Shares Short 191 (K)
Shares Short P.Month 237 (K)
Stock Financials
EPS 0.17
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 74.7
Profit Margin 0.4 %
Operating Margin 2 %
Return on Assets (ttm) 0.1 %
Return on Equity (ttm) 0.2 %
Qtrly Rev. Growth -1.5 %
Gross Profit (p.s.) 0
Sales Per Share 39.49
EBITDA (p.s.) 6.63
Qtrly Earnings Growth 387.5 %
Operating Cash Flow 44 (M)
Levered Free Cash Flow 39 (M)
Stock Valuations
PE Ratio 592.58
PEG Ratio 0
Price to Book value 1.34
Price to Sales 2.55
Price to Cash Flow 12.4
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android